Overview

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

Status:
Withdrawn
Trial end date:
2013-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and efficacy of product 0405 in pediatric subjects with Mild to Moderate Atopic Dermatitis.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Fougera Pharmaceuticals Inc.
Criteria
Inclusion Criteria:

- Clinical Diagnosis of Atopic Dermatitis

- Good health with the exception of Atopic Dermatitis

- Percent body surface area minimum requirements

Exclusion Criteria:

- Subjects who are pregnant, nursing or planning a pregnancy